Fisher Funds portfolio manager Sam Dickie says if positive vaccine news weakened the share price of Fisher & Paykel Healthcare, he’d see it as an opportunity to ‘top up’ his funds’ significant shareholding.
“Any volatility or weakness in the share price on the back of a vaccine,
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
